Tempest Therapeutics Q3 EPS $(0.21) Beats $(0.32) Estimate
Benzinga Newsdesk 6 days ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.32) by 34.38 percent. This is a 73.42 percent increase over losses of $(0.79) per share
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.32) by 34.38 percent. This is a 73.42 percent increase over losses of $(0.79) per share from the same period last year.
